Abdominal aortic aneurysm: Difference between revisions
(made image a thumbnail (reposition)) |
|||
(47 intermediate revisions by 15 users not shown) | |||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
[[File:AneurysmAortaWithArrows.jpg|thumb|CT reconstruction image of an abdominal aortic aneurysm (white arrows).]] | |||
*Infrarenal diameter >3cm or >50% increase in size of diameter | *Infrarenal diameter >3cm or >50% increase in size of diameter | ||
**85% of cases are infrarenal <ref name="NJM"></ref> | |||
*M to F ratio is 4:1 | |||
*Rupture Risk | *Rupture Risk | ||
**<4cm: low risk for rupture | **<4cm: low risk for rupture | ||
**4-5cm: 5 year risk 3-12% | **4-5cm: 5 year risk 3-12% | ||
**>5cm: 25-41% | **>5cm: 25-41% | ||
**Rupture | **Rupture possible at any size, most commonly >5cm | ||
**Mortality with rupture: 85-90% <ref name="NJM">Kent, K. Abdominal Aortic Aneurysms. The New England Journal of Medicine. 2014; 371:2101-8. DOI: 10.1056/NEJMcp1401430 </ref> | |||
===Risk Factors=== | ===Risk Factors=== | ||
*Smoking | *Smoking | ||
**Risk factor most strongly | **Risk factor most strongly associated with AAA | ||
**Also promotes the rate of aneurysm growth | **Also promotes the rate of aneurysm growth | ||
**Direct relationship between risk and number of smoking years | |||
*Age (prevalence is negligible in age <50yrs) | |||
*Family history | *Family history | ||
* | *Hypertension | ||
*Hyperlipidemia | |||
*Fluoroquinolone use <ref>P. Wendling for Medscape. FDA Warns of Aortic Aneurysm Risk with Fluoroquinolones. https://www.medscape.com/viewarticle/906867. Accessed 12/26/2018.</ref> | |||
==Clinical Features== | ==Clinical Features== | ||
* | *Classic triad is [[abdominal pain|pain]] + [[hypotension]] + pulsatile mass | ||
**Pain often described as sudden, severe, radiating to back | **Pain often described as sudden, severe, radiating to back, ripping quality | ||
*Syncope (10%) | *[[Syncope]] (10%) | ||
*Signs of [[Retroperitoneal hemorrhage]] | |||
*Massive [[GI bleed]] from [[aortoenteric fistula]] | |||
*Pain + AAA = rupture until proven otherwise | *Pain + AAA = rupture until proven otherwise | ||
*Acute abdomen + hypotension = possible rupture | *Acute abdomen + hypotension = possible rupture | ||
*Gross [[hematuria]] can be caused by an aortocaval fistula (very rare) | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{ | {{Abdominal Pain DDX Diffuse}} | ||
{{Lower back pain DDX}} | {{Lower back pain DDX}} | ||
== | ==Evaluation== | ||
[[File:AAA.png|thumb|AAA]] | [[File:AAA.png|thumb|AAA]] | ||
[[File:AAA_with_Thrombus.gif|thumbnail|Ultrasound of AAA with Thrombus (click to view).<ref>http://www.thepocusatlas.com/aorta-1/</ref>]] | |||
*[[ | [[File:AneursymCTMark.png|thumb|Abdominal aortic aneurysm seen on CT with a small area of remaining blood flow (white).]] | ||
[[File:Sagital aaa.jpg|thumb|Sagital reconstruction of aortic aneurysm]] | |||
*[[Aortic ultrasound|Ultrasound]] | |||
**~100% sensitive for increased diameter | **~100% sensitive for increased diameter | ||
**Cannot reliably visualize rupture | **Cannot reliably visualize rupture | ||
*CT | *CT | ||
**~100% sensitive for | **~100% sensitive for increased diameter and rupture | ||
**IV contrast is preferred but not essential | **IV contrast is preferred but not essential | ||
== | ==Management== | ||
===Rupture=== | ===Rupture=== | ||
[[File:RupturedAAA.png|thumb|Ruptured AAA with an open arrow marking the aneurysm and the closed arrow marking the free blood in the abdomen.]] | |||
*Do not waste time in ED trying to "stabilize" patient | |||
*Immediate surgery consultation/ go to OR | |||
*Crossmatch 6 units of pRBC | |||
*Pain control (avoid hypotension) | |||
*Antihypertensives (use with caution, goal SBP 110-120 mmHg or MAP 70-80)<ref>Reed, K. Aortic Emergencies, EB Medicine. 2006.</ref> | |||
**[[Labetalol]]: 20mg IV, then 40-80mg IV q10 min (max 300mg) | |||
**[[Esmolol]]: Bolus 500 mcg/kg, then 50-200 mcg/kg/min | |||
**[[Nitroprusside]]: 0.3 - 0.5 mcg/kg/min, titrate to max 10 mcg/kg/min | |||
*Controversial | |||
**Too little (ischemia), too much (increased bleeding) | |||
***Consider allowing for permissive hypotension (SBP 80-100) in conscious patient | |||
**[[Pressors]] | |||
***[[Norepinephrine]] 0.05mcg/kg/min IV; titrate by 0.02mcg/kg/min q5min | |||
***[[Phenylephrine]] 100-180mcg/min; titrate by 25mcg/min q10min | |||
***[[Dopamine]] 5mcg/kg/min; titrate by 5mcg/kg/min q10min | |||
===Asymptomatic=== | ===Asymptomatic=== | ||
*Prompt vascular surgery outpatient follow-up appt | *Aneurysm > 5 cm: Prompt (within days) vascular surgery outpatient follow-up appt | ||
**Endovascular (75%) vs open repair | |||
*Aneurysm 3-5 cm: Can likely follow up with PCP/surgeon on non-urgent basis | |||
*Screening frequency: | |||
**3-4 cm diameter: 12 months | |||
**4-5 cm diameter: 6 months | |||
**5-6 cm diameter: 1 month | |||
*Elective Surgery indicated if: | |||
**AAA > 5.5 cm in men <ref name="NJM"></ref> | |||
**AAA > 5 cm in women <ref name="NJM"></ref> | |||
**increase in size > 1 cm/year | |||
**increase in size > 5 mm/6 months | |||
==Complications== | |||
*[[Aortoenteric fistula]] | |||
*[[Aortocaval fistula]] | |||
*[[Inflammatory abdominal aortic aneurysm]] | |||
*[[Acute limb ischemia]] - embolism to lower extremities | |||
*Graft infection | |||
*Endoleak | |||
==Disposition== | |||
*Admit to OR in cases of ruptured OR | |||
*Vasc surgery follow up in asymptomatic cases | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category: | [[Category:Cardiology]] | ||
[[Category:Vascular]] |
Revision as of 23:02, 5 August 2020
Background
- Infrarenal diameter >3cm or >50% increase in size of diameter
- 85% of cases are infrarenal [1]
- M to F ratio is 4:1
- Rupture Risk
- <4cm: low risk for rupture
- 4-5cm: 5 year risk 3-12%
- >5cm: 25-41%
- Rupture possible at any size, most commonly >5cm
- Mortality with rupture: 85-90% [1]
Risk Factors
- Smoking
- Risk factor most strongly associated with AAA
- Also promotes the rate of aneurysm growth
- Direct relationship between risk and number of smoking years
- Age (prevalence is negligible in age <50yrs)
- Family history
- Hypertension
- Hyperlipidemia
- Fluoroquinolone use [2]
Clinical Features
- Classic triad is pain + hypotension + pulsatile mass
- Pain often described as sudden, severe, radiating to back, ripping quality
- Syncope (10%)
- Signs of Retroperitoneal hemorrhage
- Massive GI bleed from aortoenteric fistula
- Pain + AAA = rupture until proven otherwise
- Acute abdomen + hypotension = possible rupture
- Gross hematuria can be caused by an aortocaval fistula (very rare)
Differential Diagnosis
Diffuse Abdominal pain
- Abdominal aortic aneurysm
- Acute gastroenteritis
- Aortoenteric fisulta
- Appendicitis (early)
- Bowel obstruction
- Bowel perforation
- Diabetic ketoacidosis
- Gastroparesis
- Hernia
- Hypercalcemia
- Inflammatory bowel disease
- Mesenteric ischemia
- Pancreatitis
- Peritonitis
- Sickle cell crisis
- Spontaneous bacterial peritonitis
- Volvulus
Lower Back Pain
- Spine related
- Acute ligamentous injury
- Acute muscle strain
- Disk herniation (Sciatica)
- Degenerative joint disease
- Spondylolithesis
- Epidural compression syndromes
- Thoracic and lumbar fractures and dislocations
- Cancer metastasis
- Spinal stenosis
- Transverse myelitis
- Vertebral osteomyelitis
- Ankylosing spondylitis
- Spondylolisthesis
- Discitis
- Spinal Infarct
- Renal disease
- Intra-abdominal
- Abdominal aortic aneurysm
- Ulcer perforation
- Retrocecal appendicitis
- Large bowel obstruction
- Pancreatitis
- Pelvic disease
- Other
Evaluation
- Ultrasound
- ~100% sensitive for increased diameter
- Cannot reliably visualize rupture
- CT
- ~100% sensitive for increased diameter and rupture
- IV contrast is preferred but not essential
Management
Rupture
- Do not waste time in ED trying to "stabilize" patient
- Immediate surgery consultation/ go to OR
- Crossmatch 6 units of pRBC
- Pain control (avoid hypotension)
- Antihypertensives (use with caution, goal SBP 110-120 mmHg or MAP 70-80)[4]
- Labetalol: 20mg IV, then 40-80mg IV q10 min (max 300mg)
- Esmolol: Bolus 500 mcg/kg, then 50-200 mcg/kg/min
- Nitroprusside: 0.3 - 0.5 mcg/kg/min, titrate to max 10 mcg/kg/min
- Controversial
- Too little (ischemia), too much (increased bleeding)
- Consider allowing for permissive hypotension (SBP 80-100) in conscious patient
- Pressors
- Norepinephrine 0.05mcg/kg/min IV; titrate by 0.02mcg/kg/min q5min
- Phenylephrine 100-180mcg/min; titrate by 25mcg/min q10min
- Dopamine 5mcg/kg/min; titrate by 5mcg/kg/min q10min
- Too little (ischemia), too much (increased bleeding)
Asymptomatic
- Aneurysm > 5 cm: Prompt (within days) vascular surgery outpatient follow-up appt
- Endovascular (75%) vs open repair
- Aneurysm 3-5 cm: Can likely follow up with PCP/surgeon on non-urgent basis
- Screening frequency:
- 3-4 cm diameter: 12 months
- 4-5 cm diameter: 6 months
- 5-6 cm diameter: 1 month
- Elective Surgery indicated if:
Complications
- Aortoenteric fistula
- Aortocaval fistula
- Inflammatory abdominal aortic aneurysm
- Acute limb ischemia - embolism to lower extremities
- Graft infection
- Endoleak
Disposition
- Admit to OR in cases of ruptured OR
- Vasc surgery follow up in asymptomatic cases
References
- ↑ 1.0 1.1 1.2 1.3 Kent, K. Abdominal Aortic Aneurysms. The New England Journal of Medicine. 2014; 371:2101-8. DOI: 10.1056/NEJMcp1401430
- ↑ P. Wendling for Medscape. FDA Warns of Aortic Aneurysm Risk with Fluoroquinolones. https://www.medscape.com/viewarticle/906867. Accessed 12/26/2018.
- ↑ http://www.thepocusatlas.com/aorta-1/
- ↑ Reed, K. Aortic Emergencies, EB Medicine. 2006.